This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Department Of Health Working With Two Pennsylvania Pain Clinics To Notify Patients Of Possible Exposure To Fungal Meningitis

No Related Illnesses Identified in Pennsylvania

HARRISBURG, Pa., Oct. 4, 2012 /PRNewswire-USNewswire/ --  The Department of Health is working closely with two pain clinics to identify and contact patients who received a medication linked to cases of an unusual type of fungal meningitis in several other states. 

The two clinics involved are Allegheny Pain Management in Altoona, as well as South Hills Pain and Rehab Associates, with locations in Jefferson Hills, Bethel Park, Monessen and Brentwood. The Allegheny Health Department is also working with state officials regarding the South Hills Pain and Rehab Associates facilities.

At present, no cases of illness related to the use of this medication have been identified in Pennsylvania. A total of 34 cases and five deaths associated with this outbreak have been identified in six other states to date. 

The disease outbreak has been linked to three separate lots of injectable, preservative-free methylprednisolone. This medication is only used for treatment of chronic pain, usually involving injection into an area around the spinal cord known as the epidural space or into joints or muscles. The lots in question were produced by a compounding pharmacy in Massachusetts and shipped to 23 different states over the last several months.

Any remaining medication was recalled by the company last week. The clinics in Pennsylvania are no longer using the medication from the Massachusetts pharmacy.   

All patients who may have received injections from these lots are being directly contacted to identify any possible illness and assure they receive appropriate follow up. 

Fungal meningitis is not transmitted from person-to-person, and there is no cause for concern to anyone in Pennsylvania who did not receive an injection of this medication. 

Media contact: Holli Senior, 717-787-1783

SOURCE Pennsylvania Department of Health

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs